Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Reply: Novel Approach for Risk-Reducing Mastectomy: First-Stage Implant Placement and Subsequent Second-Stage Mastectomy.

Lim GH, Baildam AD.

Plast Reconstr Surg. 2019 Jul;144(1):140e. doi: 10.1097/PRS.0000000000005729. No abstract available.

PMID:
31246846
2.

Current knowledge of risk reducing mastectomy: Indications, techniques, results, benefits, harms.

Baildam AD.

Breast. 2019 Aug;46:48-51. doi: 10.1016/j.breast.2019.03.011. Epub 2019 Mar 29.

PMID:
31082761
3.

Reply to Novel Approach for Risk-Reducing Mastectomy: First-Stage Implant Placement and Subsequent Second-Stage Mastectomy.

Lim GH, Baildam AD.

Plast Reconstr Surg. 2019 Apr 15. doi: 10.1097/PRS.0000000000005729. [Epub ahead of print] No abstract available.

PMID:
31008915
4.

Novel Approach for Risk-Reducing Mastectomy: First-Stage Implant Placement and Subsequent Second-Stage Mastectomy.

Lim GH, Baildam AD.

Plast Reconstr Surg. 2018 Sep;142(3):607-610. doi: 10.1097/PRS.0000000000004635.

PMID:
29878997
5.

Risk-reducing surgery increases survival in BRCA1/2 mutation carriers unaffected at time of family referral.

Ingham SL, Sperrin M, Baildam A, Ross GL, Clayton R, Lalloo F, Buchan I, Howell A, Evans DG.

Breast Cancer Res Treat. 2013 Dec;142(3):611-8. doi: 10.1007/s10549-013-2765-x. Epub 2013 Nov 20.

PMID:
24249359
6.

Oncoplastic surgery - Standard of care.

Baildam AD.

EJC Suppl. 2013 Sep;11(2):266-7. doi: 10.1016/j.ejcsup.2013.07.042. Review. No abstract available.

7.

Contralateral mastectomy improves survival in women with BRCA1/2-associated breast cancer.

Evans DG, Ingham SL, Baildam A, Ross GL, Lalloo F, Buchan I, Howell A.

Breast Cancer Res Treat. 2013 Jul;140(1):135-42. doi: 10.1007/s10549-013-2583-1. Epub 2013 Jun 20.

PMID:
23784379
8.

Skin-sparing mastectomy.

Baildam AD.

Eur J Cancer. 2011 Sep;47 Suppl 3:S342-3. doi: 10.1016/S0959-8049(11)70196-4. Review. No abstract available.

PMID:
21944008
9.

Hyaluronan, TSG-6, and inter-α-inhibitor in periprosthetic breast capsules: reduced levels of free hyaluronan and TSG-6 expression in contracted capsules.

Tan KT, Baildam AD, Juma A, Milner CM, Day AJ, Bayat A.

Aesthet Surg J. 2011 Jan;31(1):47-55. doi: 10.1177/1090820X10391778.

10.

Tumour necrosis factor-α expression is associated with increased severity of periprosthetic breast capsular contracture.

Tan KT, Wijeratne D, Shih B, Baildam AD, Bayat A.

Eur Surg Res. 2010;45(3-4):327-32. doi: 10.1159/000321009. Epub 2010 Oct 30.

PMID:
21042029
11.

Cyclooxygenase-2 inhibition does not improve the reduction in ductal carcinoma in situ proliferation with aromatase inhibitor therapy: results of the ERISAC randomized placebo-controlled trial.

Bundred NJ, Cramer A, Morris J, Renshaw L, Cheung KL, Flint P, Johnson R, Young O, Landberg G, Grassby S, Turner L, Baildam A, Barr L, Dixon JM.

Clin Cancer Res. 2010 Mar 1;16(5):1605-12. doi: 10.1158/1078-0432.CCR-09-1623. Epub 2010 Feb 23.

12.

Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.

Evans DG, Lalloo F, Ashcroft L, Shenton A, Clancy T, Baildam AD, Brain A, Hopwood P, Howell A.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2318-24. doi: 10.1158/1055-9965.EPI-09-0171.

13.

Risk reducing mastectomy: outcomes in 10 European centres.

Evans DG, Baildam AD, Anderson E, Brain A, Shenton A, Vasen HF, Eccles D, Lucassen A, Pichert G, Hamed H, Moller P, Maehle L, Morrison PJ, Stoppat-Lyonnet D, Gregory H, Smyth E, Niederacher D, Nestle-Krämling C, Campbell J, Hopwood P, Lalloo F, Howell A.

J Med Genet. 2009 Apr;46(4):254-8. doi: 10.1136/jmg.2008.062232. Epub 2008 Nov 7.

PMID:
18996907
14.

Oncoplastic surgery for breast cancer.

Baildam AD.

Br J Surg. 2008 Jan;95(1):4-5. No abstract available.

PMID:
18161886
15.

Oncoplastic breast surgery--a guide to good practice.

Association of Breast Surgery at BASO; Association of Breast Surgery at BAPRAS; Training Interface Group in Breast Surgery, Baildam A, Bishop H, Boland G, Dalglish M, Davies L, Fatah F, Gooch H, Harcourt D, Martin L, Rainsbury D, Rayter Z, Sheppard C, Smith J, Weiler-Mithoff E, Winstanley J, Church J.

Eur J Surg Oncol. 2007 Aug;33 Suppl 1:S1-23. Epub 2007 Jul 2. No abstract available. Erratum in: Eur J Surg Oncol. 2008 Jun;34(6):II. Church, Jacqueline [added].

PMID:
17604938
16.

Breast reconstruction--state of the art.

Baildam AD.

Breast. 2006 Dec;15 Suppl 2:S27-30. Review. No abstract available. Erratum in: Breast. 2008 Apr;17(2):213.

PMID:
17382858
17.

Best surgical prophylaxis--risk-reducing mastectomy for women at high personal risk of breast cancer.

Baildam AD.

Breast. 2006 Dec;15 Suppl 2:S21-5. Review. No abstract available. Erratum in: Breast. 2008 Apr;17(2):213.

PMID:
17382857
18.

Acute chemotherapy-related toxicity is not increased in BRCA1 and BRCA2 mutation carriers treated for breast cancer in the United Kingdom.

Shanley S, McReynolds K, Ardern-Jones A, Ahern R, Fernando I, Yarnold J, Evans G, Eccles D, Hodgson S, Ashley S, Ashcroft L, Tutt A, Bancroft E, Short S, Smith I, Gui G; Royal Marsden NHS Foundation Trust, Barr L, Baildam A, Howell A, Royle G, Pierce L, Easton D, Eeles R.

Clin Cancer Res. 2006 Dec 1;12(23):7033-8.

19.

Late toxicity is not increased in BRCA1/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom.

Shanley S, McReynolds K, Ardern-Jones A, Ahern R, Fernando I, Yarnold J, Evans G, Eccles D, Hodgson S, Ashley S, Ashcroft L, Tutt A, Bancroft E, Short S, Gui G; Breast Unit of the Royal Marsden NHS Foundation Trust, Barr L, Baildam A, Howell A, Royle G, Pierce L, Easton D, Eeles R.

Clin Cancer Res. 2006 Dec 1;12(23):7025-32.

20.

Screening younger women with a family history of breast cancer--does early detection improve outcome?

Maurice A, Evans DG, Shenton A, Ashcroft L, Baildam A, Barr L, Byrne G, Bundred N, Boggis C, Wilson M, Duffy SW, Howell A.

Eur J Cancer. 2006 Jul;42(10):1385-90. Epub 2006 Jun 5.

PMID:
16750910
21.

Effects of oestrogens and anti-oestrogens on normal breast tissue from women bearing BRCA1 and BRCA2 mutations.

Bramley M, Clarke RB, Howell A, Evans DG, Armer T, Baildam AD, Anderson E.

Br J Cancer. 2006 Apr 10;94(7):1021-8.

22.

Surgical decisions made by 158 women with hereditary breast cancer aged <50 years.

Evans DG, Lalloo F, Hopwood P, Maurice A, Baildam A, Brain A, Barr L, Howell A.

Eur J Surg Oncol. 2005 Dec;31(10):1112-8. Epub 2005 Jul 7.

PMID:
16005602
23.
24.

Energy balance in early breast cancer patients receiving adjuvant chemotherapy.

Harvie MN, Campbell IT, Baildam A, Howell A.

Breast Cancer Res Treat. 2004 Feb;83(3):201-10.

PMID:
14758090
25.

Changes in body composition in men and women with advanced nonsmall cell lung cancer (NSCLC) undergoing chemotherapy.

Harvie MN, Campbell IT, Thatcher N, Baildam A.

J Hum Nutr Diet. 2003 Oct;16(5):323-6.

PMID:
14516379
26.

Management of accessory breast tissue in the axilla.

Down S, Barr L, Baildam AD, Bundred N.

Br J Surg. 2003 Oct;90(10):1213-4.

PMID:
14515288
27.

Long term results of a randomised prospective study of preservation of the intercostobrachial nerve.

Freeman SR, Washington SJ, Pritchard T, Barr L, Baildam AD, Bundred NJ.

Eur J Surg Oncol. 2003 Apr;29(3):213-5.

PMID:
12657228
28.

Oncoplastic surgery of the breast.

Baildam AD.

Br J Surg. 2002 May;89(5):532-3. No abstract available.

PMID:
11972541
29.

Increased soluble intercellular adhesion molecule-1, breast cancer and the acute phase response.

Blann AD, Byrne GJ, Baildam AD.

Blood Coagul Fibrinolysis. 2002 Mar;13(2):165-8.

PMID:
11914659
30.

Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial.

Dey P, Bundred N, Gibbs A, Hopwood P, Baildam A, Boggis C, James M, Knox F, Leidecker V, Woodman C.

BMJ. 2002 Mar 2;324(7336):507.

31.

Re: risk-reduction mastectomy: clinical issues and research needs.

Evans DG, Howell A, Baildam A, Brain A, Lalloo F, Hopwood P.

J Natl Cancer Inst. 2002 Feb 20;94(4):307-8. No abstract available.

PMID:
11854394
32.

Tamoxifen increases von Willebrand factor in women who underwent breast cancer surgery.

Blann AD, Baildam AD, Howell A, Miller JP.

Thromb Haemost. 2001 May;85(5):941-2. No abstract available.

PMID:
11372695
33.
34.

Clinical follow-up after bilateral risk reducing ('prophylactic') mastectomy: mental health and body image outcomes.

Hopwood P, Lee A, Shenton A, Baildam A, Brain A, Lalloo F, Evans G, Howell A.

Psychooncology. 2000 Nov-Dec;9(6):462-72.

PMID:
11180581
35.

Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ.

Chan KC, Knox WF, Sinha G, Gandhi A, Barr L, Baildam AD, Bundred NJ.

Cancer. 2001 Jan 1;91(1):9-16.

PMID:
11148554
36.

A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancer.

Lalloo F, Baildam A, Brain A, Hopwood P, Evans DG, Howell A.

Eur J Surg Oncol. 2000 Nov;26(7):711-3.

PMID:
11078619
37.

Postoperative nausea and vomiting in women following breast surgery: an audit.

Jaffe SM, Campbell P, Bellman M, Baildam A.

Eur J Anaesthesiol. 2000 Apr;17(4):261-4.

PMID:
10866010
38.

The role of bilateral prophylactic mastectomy (BPMX) in women at high risk of breast cancer.

Baildam AD.

Dis Markers. 1999 Oct;15(1-3):197-8. No abstract available.

39.

Acute inflammatory (non-purulent) arthritis concomitant with a developing breast abscess.

Pal B, Jones P, Baildam AD.

Scand J Rheumatol. 1999;28(2):123-4.

PMID:
10229144
40.

Randomised controlled trial of effects of early discharge after surgery for breast cancer.

Bundred N, Maguire P, Reynolds J, Grimshaw J, Morris J, Thomson L, Barr L, Baildam A.

BMJ. 1998 Nov 7;317(7168):1275-9.

41.

Prospective randomized controlled trial of preservation of the intercostobrachial nerve during axillary node clearance for breast cancer.

Abdullah TI, Iddon J, Barr L, Baildam AD, Bundred NJ.

Br J Surg. 1998 Oct;85(10):1443-5.

PMID:
9782034
42.

The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ.

Holland PA, Gandhi A, Knox WF, Wilson M, Baildam AD, Bundred NJ.

Br J Cancer. 1998;77(1):110-4.

43.

Magnetic resonance imaging of bone metastases: a diagnostic and screening technique.

Downey SE, Wilson M, Boggis C, Baildam AD, Howell A, Bundred NJ.

Br J Surg. 1997 Aug;84(8):1093-4. No abstract available.

PMID:
9278648
44.

Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast.

Holland PA, Knox WF, Potten CS, Howell A, Anderson E, Baildam AD, Bundred NJ.

J Natl Cancer Inst. 1997 Jul 16;89(14):1059-65.

PMID:
9230888
45.

Cyclosporin A and multiple fibroadenomas of the breast.

Baildam AD, Higgins RM, Hurley E, Furlong A, Walls J, Venning MC, Ackrill P, Mansel RE.

Br J Surg. 1996 Dec;83(12):1755-7.

PMID:
9038560
46.

A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening rounds.

Holland PA, Walls J, Boggis CR, Knox F, Baildam AD, Bundred NJ.

Br J Cancer. 1996 Nov;74(10):1643-6.

47.

Management of premenopausal women with primary breast cancer.

Woodman CB, Singleton J, Coyne J, Baildam A.

Br J Surg. 1996 Sep;83(9):1256-7. No abstract available.

PMID:
8983621
48.

Hormone replacement therapy and tumour grade in breast cancer: prospective study in screening unit.

Harding C, Knox WF, Faragher EB, Baildam A, Bundred NJ.

BMJ. 1996 Jun 29;312(7047):1646-7. No abstract available. Erratum in: BMJ 1996 Jul 27;313(7051):198.

49.

Membranous fat necrosis of the breast.

Coyne JD, Parkinson D, Baildam AD.

Histopathology. 1996 Jan;28(1):61-4.

PMID:
8838122
50.

Lobular carcinoma of the breast can be managed by breast-conserving therapy.

Holland PA, Shah A, Howell A, Baildam AD, Bundred NJ.

Br J Surg. 1995 Oct;82(10):1364-6.

PMID:
7489166

Supplemental Content

Loading ...
Support Center